コロンビア特別区における膠腫の臨床試験
コロンビア特別区内の拠点で、膠腫に関する14件の研究が参加者を募集しています。
コロンビア特別区内の都市
公式研究テキスト（英語）
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's National Medical Center, Washington D.C.
被験者募集中第1/2相
12 Months – 21 Years · 全性別 · 2026/10/01更新 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Children's National Medical Center, Washington D.C.
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/09/21更新 · NCT06838676NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
- Children's National Hospital, Washington D.C.
被験者募集中第1相
3歳〜25歳 · 全性別 · 2026/09/09更新 · NCT07664176Targeted Pediatric High-Grade Glioma Therapy
- Children's National Medical Center, Washington D.C.
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's National Medical Center, Washington D.C.
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's National Medical Center, Washington D.C.
被験者募集中第2相
3歳〜39歳 · 全性別 · 2026/08/24更新 · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's National Medical Center, Washington D.C.
被験者募集中第1相
1歳〜25歳 · 全性別 · 2026/08/18更新 · NCT04485559MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Children's National Hospital, Washington D.C.
被験者募集中第1/2相
1歳〜26歳 · 全性別 · 2026/07/10更新 · NCT06712875Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's National Medical Center, Washington D.C.
被験者募集中早期第1相健康なボランティア歓迎
1歳〜21歳 · 全性別 · 2026/06/29更新 · NCT06333899A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- Children's National Hospital, Washington D.C.
被験者募集中第1相
4歳以上 · 全性別 · 2026/06/25更新 · NCT04573140Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's National Medical Center, Washington D.C.
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Children's National Medical Center, Washington D.C.
被験者募集中早期第1相
21歳以下 · 全性別 · 2026/03/18更新 · NCT04655404ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。